Skip to content

Enteral Formula Tolerance in Pediatric Patients

Enteral Formula Tolerance in Pediatric Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02779335
Enrollment
22
Registered
2016-05-20
Start date
2016-05-31
Completion date
2016-10-31
Last updated
2016-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Enteral Nutrition

Keywords

tube-fed, Formula Tolerance, Pediatric Patients

Brief summary

The purpose of this prospective study seeks to assess ability to achieve enteral feeding goals with standard polymeric enteral formula in a stable, pediatric tube-fed population.

Detailed description

In this prospective study, a population of stable, tube-fed children will consume a standard polymetric tube feeding formula to assess ability to achieve enteral feeding goals and tolerance outcomes.

Interventions

pediatric subjects will be fed a standard pediatric enteral formula tube feeding

Sponsors

Société des Produits Nestlé (SPN)
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Years to 13 Years
Healthy volunteers
No

Inclusion criteria

* 1 - 13 years of age * Currently tolerating enteral feeding * Has enteral access * Requires enteral tube feeding to provide 90% or more of their nutritional needs (without the use of modular(s)) for at least 9 days * Having obtained his/her and/or his/her legal representative's informed consent

Exclusion criteria

* Condition which contraindicates enteral feeding (i.e. intestinal obstruction) * Lack of enteral access * Any condition that would contraindicate use of the study product (i.e. need for severe fluid restriction, cow's milk protein allergy, other) * Judged to be at risk for poor compliance to the study protocol * Lack of informed consent * Currently participating in another conflicting clinical trial

Design outcomes

Primary

MeasureTime frame
Daily percentage of caloric nutritional goal met9 days

Secondary

MeasureTime frameDescription
Daily assessment of gastrointestinal tolerance - Flatulence9 daysDaily assessment of presence of flatulence
Daily assessment of gastrointestinal tolerance - Abdominal pain9 daysDaily assessment of abdominal pain
Frequency and nature of adverse events9 days
Daily assessment of gastrointestinal tolerance- Vomit9 daysDaily assessment of frequency of vomit
Daily assessment of gastrointestinal tolerance- Stool frequency9 daysDaily assessment of number of stool
Daily percentage of protein goal met9 days
Daily assessment of gastrointestinal tolerance - stool consistency9 daysDaily assessment of stool consistency (liquid, formed, soft)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026